15 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Navidea Biopharmaceuticals Inc NAVB shares rose 62.6 percent to $0.555 in pre-market trading as the company announced a Letter of Intent to sell Lymphoseek in North America to Cardinal Health Inc CAH.
• CoLucid Pharmaceuticals Inc CLCD rose 58.4 percent to $16.89 in pre-market trading after the company disclosed the achievement of both the primary and secondary endpoints in the SAMURAI Phase 3 trial of lasmiditan.
• Cepheid CPHD shares rose 52.3 percent to $52.41 in pre-market trading. Danaher Corporation DHR disclosed Tuesday that it reached a definitive merger deal with Cepheid to buy the latter for $53.00 a share in cash.
• Navistar International Corp NAV rose 27.7 percent to $17.97 in the pre-market trading after the company disclosed a 16.6 percent stake by Volkswagen AG (ADR) VLKAY.
• Threshold Pharmaceuticals, Inc. THLD rose 15.7 percent to $1.40 in pre-market trading after surging 15.24 percent on Friday.
• Karyopharm Therapeutics Inc KPTI rose 12.2 percent to $11.92 in pre-market trading after the company reported positive Phase 2b STORM results.
• Spectra Energy Corp. SE rose 7.9 percent to $39.00 in the pre-market trading session. Enbridge Inc (USA) and Spectra Energy Corp. agreed to merge in an all-stock transaction.
• ITT Educational Services, Inc. ESI rose 7.3 percent to $0.384 in pre-market trading. ITT Educational announced plans to cease operations at all its ITT Technical Institutes.
• Sangamo Biosciences, Inc. SGMO shares rose 3.7 percent to $4.48 in pre-market trading as the company disclosed that it has received orphan drug designation from the FDA for SB-FIX.
• Exelixis, Inc. EXEL shares rose 3.1 percent to $11.90 in pre-market trading after gaining 1.67 percent on Friday.
• Medpace Holdings Inc MEDP rose 2.5 percent to $31.48 in pre-market trading. Credit Suisse initiated coverage on Medpace Holdings with an Outperform rating, while UBS initiated coverage on the stock with a Buy rating. Wells Fargo also initiated coverage on Medpace with an Outperform rating.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Tonix Pharmaceuticals Holding Corp. TNXP shares fell 16.1 percent to $1.83 in pre-market trading as the company disclosed that its Phase 3 clinical study, AFFIRM, missed the primary efficacy endpoint.
• Marvell Technology Group Ltd. MRVL shares fell 5.5 percent to $12.30 in pre-market trading after the company announced mixed results for the second quarter. While adjusted EPS came in above expectations, revenue fell shy of the estimates.
• Skypeople Fruit Juice Inc SPU shares fell 3.7 percent to $12.15 in pre-market trading after gaining 9.46 percent on Friday.
• Enbridge Inc (USA) ENB shares fell 2 percent to $40.25 in pre-market trading. Enbridge Inc (USA) and Spectra Energy Corp. agreed to merge in an all-stock transaction.